Table 1

Key themes highlighting survivors’ and caregivers’ barriers and facilitators to adherence to secondary prevention medications classified according to perceptions and practicalities.

Sample characteristicsNMedian range
Total participants identified in posts84
Number of posts in the forum/ participant16 (1–4932)
Number of posts about secondary prevention medications/ participant1 (1–37)
Age at stroke
  Survivor50 (32–72)
  Patient by caregiver66 (46–91)
Gender
  Male—survivor20
  Female—survivor26
  Not known—survivor3
  Male—patient talked about by caregiver20
  Female—patient talked about by caregiver12
  Unknown gender and unknown identity3
Identity person posting
  Stroke survivor49
  Caregiver33
  Not known2
Years since stroke
  (0–12 months)37
  (1–5 years)25
  (6–10 years)4
  (11–15 years)2
  (15+ years)1
  Unknown15
Caregiver identity
  Daughter/son20
  Spouse9
  Other (/in-law/ sister)3
  Unknown1